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Human cytomegalovirus (HCMV) is one of the most common viruses they can
be transmitted through the placenta. Congenital HCMV infection has been a
focus of perinatal medicine, pediatrics, and virology in recent years. In
pregnant women, the incidence of HCMV infection in China accounts for
more than 90%, while, the incidence in infants is 1%. Domestic and foreign
large-scale studies have shown that 10% of newborns with congenital HCMV
infection, are symptomatic and have clinical symptoms at birth, while 90% are
asymptomatic. Developing countries have a higher incidence of HCMV
infection than developed countries.
1-4 However, little attention has been
focused on the influence of congenital HCMV infection on children’s physical
growth and intellectual development. By following-up asymptomatically
infected infants from July 2003 to July 2007, we investigated changes in
audiology, nervous behavior, intellectual development, and behavioral
development in order to find out the impact of asymptomatic congenital
HCMV infection.  
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Purpose: To observe changes in audiology, intellectual development, behavior development, and physical growth
during systematic follow-up of infants with asymptomatic congenital human cytomegalovirus (HCMV) infection.
Materials and Methods: Fifty-two infants diagnosed with asymptomatic congenital HCMV infection from July
2003 to July 2007 served as the infection group, and 21 healthy infants served as the control group. All infants were
confirmed to have HCMV infection by Fluorescent Quantative polymerase chain reaction (FQ-PCR). In both the
infection and control groups, the neonates and infants at 3 months, 6 months, and 1 year of age underwent
examinations. Results: 1) 20 items of National Black Nurses Association (NBNA) scores of neonates 12-14 days
after birth in 2 groups were 38.3 ± 1.95 and 38.5 ± 2.29, without significant differences. 2) Auditory test: 50 ears of
25 cases in the infection group showed abnormal auditory thresholds in V waves with an abnormal rate of 14%,
while no abnormalities were found in 21 cases in the control group. 3) Mental and psychomotor development index
scores in the control group (107.49 ± 11.31 and 107.19 ± 10.98) were compared with those in 41 asymptomatically
infected infants at 1 year of age (107.21 ± 9.96 and 108.31 ± 11.25), and no statistically significant difference was
noted. Conclusion: 1) An elevated threshold in the V wave was present in asymptomatically infected infants, but
could not be detected through otoacoustic emission (OAE) screening. 2) Either in the neonatal or infant periods,
asymptomatic congenital HCMV infection did not have a significant influence on nervous behavior or on physical
and intellectual development.
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Subjects 
Fifty-four term neonates who came from the newborn
nursery and obstetric ward from July 2003 to July 2007
were diagnosed with asymptomatic congenital HCMV
infection in the first two weeks after birth. Fifty-two cases
were selected and enrolled in the infection group as pre-
viously described, including 30 boys and 22 girls with an
average birth weight of 3.39 ± 0.31 kg, whereas 21 cases
served as the control group, including 11 boys and 10 girls
with an average birth weight of 3.31 ± 0.38 kg.
Diagnostic criteria of asymptomatic congenital HCMV
infection
In this study, congenital HCMV infection was diagnosed if
HCMV-DNA of blood cell (WBC) is positive in 14 days.
Asymptomatic congenital HCMV infection was identified
according to the American Fowler criteria
5 and the follow-
ing conditions: 
1) At least 1 positive result for HCMV-immunoglobulin
M (IgM) or HCMV-DNA was detected in the mother’s
blood, urine, or breast milk.
2) 14 d after birth, positive HCMV DNA was found in
white blood cell (WBC) in infants, while results of other
virologic investigation by Toxoplasma Other Rubella
Virus Cytogegalo Virus, Herpes Simplex Virus-II -
polymerase chain reaction (TORCH-PCR) were negative
(without rubella virus, toxoplasmosis, herpes simplex
virus, and others). 
3) HCMV-infected infants with the following clinical
symptoms were ruled out: ecchymosis, thrombocytopenia,
hepatosplenomegaly, hyperbilirubinemia caused by direct
increase of bilirubin, and microcephalia. 
HCMV-infected infants with the following diseases
were excluded: severe asphyxia, hypoxic-ischemic ence-
phalopathy (HIE), central nervous system infection, con-
genital malformation, family history of hearing impair-
ment, receiving ototoxic drug, or receiving mechanical
ventilation. 
Infants in the control group were at the same stage as the
infection group. Precautions were implemented to ensure
that all control group conditions were the same as those of
the infection group, with the exception of a negative result
upon cytomegalovirus infection examination.
Testing  methods 
Collecting venous blood samples
Two mL venous blood of infants were obtained imme-
diately after admission and stored at -20˚C for further
detection. 
Detecting sera HCMV-DNA with Fluorescence Quantita-
tive polymerase chain reaction (FQ-PCR)
Primers used for HCMV-DNA amplification were as
follows: p1 5’-TTT ABA TAT CCT ABA TAA GGT
TCA T-3’ and p2 5’-TCT TAA AAB ATC TTC TGG
GAA TAA GTC-3’, with a length of 235 bps products.
Fluorescent probe sequence was 5’-ABC CAT CC CAT
CTC CCGG CTT ATC CTC-3’. Quality control was
performed in strict accordance with operating manual
instructions. The automatic fluorescence gene analyzer
PE-5700 was provided by Whatman Biometra Company,
Germany.
Observation methods and procedures
In 2 groups, infants at the neonatal stage underwent 20
neonatal behavioral neurological assessment (NBNA) items.
Follow-up occurred at 3 months, 6 months, and 1 year of
age, distortion product otoacoustic emission (DPOAE) and
auditory brainstem responses (ABR) were conducted to
determine hearing loss. At the same time, Bayley Scales of
Infant Development Assessment, physical examination, and
motor nerve inspection were used to determine intellectual
and physical development. The examiners were blinded as
to which infants were in the control group and which infants
were in the infection group for both hearing and intelligent
quotients. Some infants were examined with cranial B-
ultrasonography and CT scan.
NBNA in neonatal period
Five parts (20 items) of the NBNA, including behavioral
ability, active muscular tension, passive muscle tension,
primitive reflexes, and general condition, were performed
on infants at 12 to 14 d after birth. Each of item  had 3 gra-
duations in scores 0, 1, and 2, with total score of 40 points.
Audiology follow-up method
DPOAE examination
This was performed in a quiet room by a trained examiner.
When examined, the diseased child was quiet and in a
sleeping state (without the use of sedative drugs). The
external auditory canal was conventionally cleaned, after
which a suitable detecting head was placed in the canal
with its tip-pinhole aimed at the eardrum.
ABR examination
Doctors specialized in ear nose and throat (ENT) depart-
ment were responsible for the operation and judgment of
results. ABR examination was conducted at 3 to 6 months
of age after birth by using auditory evoked potential
MATERIALS AND METHODSdiagnostic systems (Smart Ep) provided by the American
Hearing Company (HIS). After taking sedatives, the
sleeping infants were examined in an echoic room.
Separate criteria for the impairment of hearing function
were as follows: mild (hearing threshold, 26-40 dBHL),
moderate (hearing threshold, 41-55 dBHL), moderate to
severe (hearing threshold, 56-70 dBHL), severe (hearing
threshold, 71-90 dBHL), and extremely severe (hearing
threshold, above 90 dBHL).
Follow-up observation of the intelligence quotient 
The Bayley Scales of Infant Development Assessment
comprise an intelligence scale and movement scale which
were used by a trained examiner to determine infants’
intellectual and physical development. The first and
second examinations were performed at 6 months and 1
year after birth, respectively. 
Physical development examination
Length, weight, and head circumference were measured
during a physical examination.
Statistical methods
t-test and χ 2 test were used to determine significant dif-
ferences. All data were analyzed using SPSS11.0 Software.
Comparison of general conditions in infection and 
control groups
Many factors, such as family structure, economic situation,
educational background of parents, children’s guardian’s
educational background, and children’s early education,
can have an impact on children’s intellectual development.
For this reason, the aforementioned factors in the two
groups were compared. However, no significant differ-
ences were found. Moreover, no significant differences
existed in the physical examination between the two
groups. Some signs and symptoms, including bleeding
tendency, thrombocytopenia, jaundice, and hepatospleno-
megaly, were not observed in both groups.
Twenty items of NBNA
Infants scores 12 to 14 d after birth in the 2 groups were
38.3 ± 1.95 and 38.5 ± 2.29, respectively, without signi-
ficant differences (t  = 0.88, p > 0.05). 
Results of audiological follow up
ABR examination 
Twenty five cases between 3 months and 6 months of age
in the infection group were examined with ABR. Seven
ears of 5 cases showed mild abnormal auditory thresholds
in V waves with an abnormal rate of 14%, while no
abnormalities were found in 21 cases in the control group.
Therefore, the difference between the 2 groups was stati-
stically significant. Five ears in 4 cases in the infection
group showed prolonged intervals in I-V waves, whereas 3
ears in 2 cases in the control group showed this abnor-
mality without apparent differences. All infants with the
increased V wave threshold were subjected to OAE ins-
pection during the neonatal period.
OAE examination
All infants in both the infection and control groups success-
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Table 2.Comparison of Intellectual Development in 2 Groups (x ± s) 
Groups MDI PDI
Infection group (38 cases) 107.21 ± 9.96* 108.31 ± 11.25
�
Control group (21casses) 107.49 ± 11.31 107.19 ± 10.98
t 0.38 0.40
MDI, mental development index; PDI, psychomtive development index. 
*MDIs of congenital HCMV infection and the control group were compared, t = 0.38, p> 0.05.
�PDIs of congenital HCMV infection and the control group were compared, t = 0.40,  p> 0.05.
Table 1.Comparison of Abnormal ABR
Groups
V wave threshol I-V wave interval
Normal Mild abnormal Normal Prolonged 
Infection group (25 cases, 50 ears) 43 7* 45 5
�
Control group (21 cases, 42 ears) 42 0 39 3
p 0.012 0.628
ABR, auditory brainstem responses.
*Abnormality of the V wave threshold was compared between 2 groups, p= 0.012, p< 0.05.
�Abnormality of the I-V wave interval was compared between 2 groups, p= 0.628, p> 0.05.
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fully passed the inspection.
Intelligence development condition
The Bayley Scales of Infant Development Assessment
were performed in 41 cases in the infection group at year
1. No significant differences in mental development index
(MDI) and psychomtive development index (PDI) were
found between the infection and control groups (Table 2).
Cranial imaging examination 
Cranial B-ultrasonography was conducted on 23 infants
and cranial CT scan was performed in 7 cases, but no
abnormalities were found.
Considerable diversity in HCMV infection rates (ranging
from 82.5% to 95%) appears to occur in child-bearing wo-
men of different geographic regions and different ethnic
backgrounds. In China, the HCMV infection rate of preg-
nant women is more than 90%.
1 It differs from other
viruses with easy vertical transmission such as rubella as
HCMV can be transmitted to the fetus even if precon-
ception maternal immunity is present. Congenital HCMV
infection is found in approximately 1% of neonates in
China, of which 10% are symptomatic and 90% are asym-
ptomatic. If China’s annual birth of newborns is 17 to 20
million, it is estimated that nearly 200,000 neonates each
year are born with congenital HCMV infection, of which
approximately 180,000 have asymptomatic infections.
Therefore, this population requires further attention. 
Symptomatically congenital HCMV-infected infants
have poor prognoses. It has been reported that 30% of
diseased children die, while the other 70% have central
nervous system impairment of different degrees, including
mental retardation, movement disorders, and sensorineural
hearing loss (SNHL). It is generally thought that sympto-
matic congenital HCMV infection is a major cause of
death and disablement in children with intrauterine infec-
tions. Some research has shown that antiviral therapy for
symptomatically infected infants could indeed reduce the
incidence of central nervous system sequelae.
6 Regarding
asymptomatic infection, which affects the highest propor-
tion of infants with congenital HCMV infection, problems
related to infected children’s growth and early clinical use
of antiviral drugs remains unclear. 
Our study indicated that asymptomatic congenital
HCMV infection had an impact on infant hearing. The
ABR abnormality presented mainly as a slightly increased
threshold in the V wave (accounting for 14.0%), which
was similar to most studies reported abroad. Through
comparison with a control group which consisted of siblings
or randomly selected children, Fowler, et al.
5 reported that
SNHL was only found in the infection group, with the
infection rate being 7.2%. Numazaki and Fujikawa
3 found
that, among 17 cases of asymptomatic congenital HCMV
infection, 2 children developed late-onset SNHL, including
1 case of moderately binaural hearing loss and 1 case of
unilateral hearing loss. In addition, asymptomatic con-
genital HCMV infection can display delayed and fluctua-
tion phenomena in hearing problems, as described in other
studies. Because of the short time used for audiological
observation in this study, we did not observe these pheno-
mena. The mechanism of hearing impairment in children
with asymptomatic congenital HCMV infection remains
unknown at present. 
Early examination should be done to screen for HCMV.
However, most countries do not undertake HCMV screen-
ing, therefore, most congenital HCMV infection, especially
congenital asymptomatic infection, would forgo diagnosis
due to no obvious clinical manifestations. At present, OAE
is commonly used in clinics to screen newborns for hear-
ing loss. However, not all SNHL cases can be detected by
OAE, resulting in a lack of early diagnosis of SNHL.
Therefore, it is necessary to perform HCMV screening for
infants and hearing tests for congenital HCMV-infected
newborns. Some scholars believe that urine CMV-PCR
testing is convenient and simple,
7 and can be used as a
supplement for conventional laboratory tests.
8
Some factors influencing infant IQ were excluded,
including children’s family structure, economic situation,
pregnancy age, educational background of the parents,
body mass of the parents, and children’s early education,
as well as the children’s guardians and their educational
background. By following up asymptomatically-infected
infants using Bayley Scales of Infant Development Assess-
ment, we found that either MDI or PDI in the control and
infection groups had no statistically significant difference.
The results agreed with the consequence proposed by
Sten-A,
9 namely that asymptomatic congenital HCMV
infection did not have a significant influence on total IQ of
the infants.
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